HUM vs ILMN: fair value comparison
Humana Inc. and Illumina, Inc. · Updated 2026-09-12
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, ILMN currently sits closer to the top of our discount ranking. ILMN carries the stronger quality grade.
| HUM | ILMN | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $409.80 | $207.13 |
| 12-month range | $176.95–$394.88 | $102.26–$207.13 |
| Sector rank | #110 of 113 Healthcare | #106 of 113 Healthcare |
| Quality grade | F | C |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Stable |
| Revenue growth | Strong | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Fairly Valued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: HUM fair value analysis · ILMN fair value analysis